Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in NERV — Minerva Neurosciences, Inc.

CIK 1214717 BOSTON, MA
Back to NERV Full portfolio

Position in NERV

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$5,407,009
+$3,366,132 QoQ
Shares Held
974,236
+187.6% QoQ
Ownership
2.04%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 58 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NERV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. NERV ranks #231 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in NERV

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,407,009 974,236
2026-03-31 $2,040,877 338,735
2025-12-31 $281,073 69,919
2025-09-30 $159,190 75,625
2025-06-30 $130,074 75,625
2025-03-31 $130,443 76,732
2024-12-31 $125,444 56,456
2024-09-30 $150,737 56,456
2024-06-30 $175,803 55,111
2024-03-31 $135,687 52,592
2023-12-31 $320,365 52,092
2023-09-30 $359,434 52,092
2023-06-30 $474,950 51,964
2023-03-31 $65,702 41,064
2022-12-31 $65,291 41,064
2022-09-30 $367,695 39,837
2022-06-30 $131,860 39,837
2022-03-31 $251,670 303,218
2021-12-31 $383,718 479,049
2021-09-30 $850,534 488,813
2021-06-30 $1,034,207 445,779
2021-03-31 $2,027,069 694,202
2020-12-31 $1,445,244 617,626
2020-09-30 $1,933,999 608,176
2020-06-30 $1,972,193 546,314
2020-03-31 $2,956,397 491,096